Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes

In Boston on June 29, 2026, Elicio Therapeutics, Inc. (Nasdaq: ELTX) revealed that it has been included in the Russell 2000 ® and Russell 3000 ® Indexes. This change came into effect after the U.S. market closed on June 26, 2026, during the annual reconstitution of the 2026 Russell indexes. Elicio is a clinical-stage biotechnology company focused on developing advanced immunotherapies for cancers fueled by KRAS.